NCT03977636 (DALDIM) is a clinical trial in Quality Control, sponsored by Centre Hospitalier Régional Metz-Thionville.

Who is sponsoring NCT03977636?

NCT03977636 is sponsored by Centre Hospitalier Régional Metz-Thionville.

What condition does NCT03977636 study?

NCT03977636 studies Quality Control.

Is NCT03977636 still recruiting?

NCT03977636 is currently completed. Last updated 6 June 2019.

Last reviewed 2019-06-06 · How we verify

NCT03977636: DALDIM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determinants of Time Required by Medical Information Technicians for Quality Control of Hospital Activity Coding

Completed Last updated 6 June 2019

What this trial tests

trial in Quality Control in 5,431 participants. Completed in 1 June 2019.

Timeline

22 March 2016

Primary endpoint
18 January 2017

1 June 2019

Quick facts

Lead sponsor	Centre Hospitalier Régional Metz-Thionville
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5,431
Start date	22 March 2016
Primary completion	18 January 2017
Estimated completion	1 June 2019

Conditions studied

Quality Control — all drugs for Quality Control →

Sponsor

Centre Hospitalier Régional Metz-Thionville

Who can join

Eligibility, any sex, with Quality Control. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Since 2008, in France, hospital funding is determined by the nature of activities provided (activity-based funding). Quality control of hospital activity coding is essential to optimize hospital remuneration. There is a need for reliable tools to allocate human resources wisely in order to improve these controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Quality Control

Currently open trials in the same condition.

NCT07524998 — A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease · recruiting

Other Centre Hospitalier Régional Metz-Thionville trials

Trials by the same sponsor.

NCT07435389 — VENTILATION DURING SPACEFLIGHT (PHASE 2) · NA · not yet recruiting
NCT07405996 — Referral of Patients With Biological Abnormalities to an Emergency Department · not yet recruiting
NCT07406022 — Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis. · not yet recruiting
NCT07515404 — A New Multimodal and Semi-specific Therapeutic Plasmapheresis Concept, a Case Series Study · completed
NCT07390604 — Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patien · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03977636 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Régional Metz-Thionville
Last refreshed: 6 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03977636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing